Asian Pharma Stocks Dropping As US Cuts Drug Prices
Pharma Marketing Network
MAY 11, 2025
Imagine building a skyscraper only to find the foundation cracking beneath your feet. Thats how investors are feeling about Asian pharma stocks right now. As the U.S. accelerates its crackdown on drug pricing through new legislation and regulatory enforcement, pharma companies in China, India, Japan, and South Korea are feeling the ripple effect. Despite years of bullish momentum, the Asian pharma sector has taken a hit in 2024and the pain may not be short-lived.
Let's personalize your content